PERSONALIZED MEDICINE | In an Era of Health Care Reform

In partnership with the Food and Drug Law Institute (FDLI), AAAS is convening a two-day colloquium on personalized medicine on October 26-27, 2009 at AAAS headquarters in Washington, DC. This event is the second in a series of three colloquia.

The first colloquium was held on June 1-2, 2009 and can be viewed via webcast at http://www.aaas.org/spp/PM/Agenda.

The colloquium will address personalized medicine through a health care reform lens.

Keynote speaker Francis Collins, NIH Director, will explain how his agency is addressing the scientific and policy challenges of personalized medicine, and a FDA official is invited to describe that agency’s role in personalized medicine. Other topics will include comparative effectiveness research; the use of health IT in research and clinical practice, as well as the ethical, legal, and policy implications of the transition to electronic health records; and the status of biomarker research, along with case studies illustrating the application of that research in targeting drug treatment, refining doses, and avoiding adverse events. At the colloquium’s conclusion, a panel will interact with the audience to discuss the difficult choices involved in clinical care in an era of personalized medicine from the perspective of a physician, a patient, an insurance official, and an attorney.

The colloquia series is free and open to the public, but registration is required.

WHAT: Colloquium II Personalized Medicine in an Era of Health Care Reform

WHEN: October 26-27, 2009

WHERE: AAAS Headquarters 1200 New York Ave., NW Washington, DC (12th and H Street entrance)

REGISTER: http://www.aaas.org/spp/PM/colloquia2